SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Pharmaceuticals informs about open offer

26 Dec 2022 Evaluate

Suven Pharmaceuticals has informed that, Kotak Mahindra Capital Company (‘Manager to the Open Offer’) has submitted to BSE a copy of Public Announcement for the attention of the public shareholders of Suven Pharmaceuticals (‘Target Company’) under Regulation 3(1) and Regulation 4 read with Regulations 13, 14 and 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto.

The above information is a part of company’s filings submitted to BSE.




Cohance Lifesciences Share Price

369.35 -22.25 (-5.68%)
20-Apr-2026 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.50
Dr. Reddys Lab 1233.20
Cipla 1232.00
Zydus Lifesciences 937.70
Lupin 2327.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×